Stephen D. Silberstein, MD
Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
0.5 AMA PRA Category 1 Credit™
Mobile + Online on QuantiaMD
Migraine is underdiagnosed and frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to manage migraine in adult patients, resulting in improved outcomes for patients.
Internal medicine/primary care physicians, nurse practitioners (NPs) and physician assistants (PAs), neurologists, and other clinicians involved in the management of patients with migraine.
Upon completion of this educational activity, the participant should be able to:
- Review current evidence-based pharmacologic treatment options for the management of acute migraine.
- Review current evidence-based pharmacologic and nonpharmacologic treatment options for the prevention of chronic migraine.
- Recall strategies for preventing and managing non-headache symptoms of migraine.
Dr. Silberstein discloses the following conflicts of interest.
Consultant: Alder Biopharmaceuticals; Allergan, Inc.; Amgen; Avanir Pharmaceuticals, Inc.; Curelator, Inc.; Depomed; Dr. Reddy's Laboratories; eNeura Inc.; ElectroCore Medical, LLC; Lilly USA, LLC; Supernus Pharmaceuticals, Inc.; Teva Pharmaceuticals; Trigemina, Inc.
Lillian McVey, MCM Education medical writer, has no conflicts of interest to disclose.
Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.
Terry Ann Glauser, MD, MPH, Vice President, Medical Affairs, MCM Education, has no conflicts of interest to disclose.
Purdue University requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Purdue University College of Pharmacy and MCM Education. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support Statements
This activity is supported by educational grants from Avanir Pharmaceuticals and Amgen.
- Accessing Activity:
* Click "Start Program" and log into program on QuantiaMD.com
* Take the pre-test
* Review the activity
* Take the post-test and score 80%
* You are allowed a total of 3 attempts
* Complete the evaluation
* View, print, or save a CME certificate verifying your
credit/participation in this activity
- Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
There is no charge for CME credit.
©2017 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Purdue University, Avanir Pharmaceuticals, or Amgen. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.